Publications by authors named "Johnny Ribeiro"

7Publications

BMP9, but not BMP10, acts as a quiescence factor on tumor growth, vessel normalization and metastasis in a mouse model of breast cancer.

Authors:
Marie Ouarné Claire Bouvard Gabriela Boneva Christine Mallet Johnny Ribeiro Agnès Desroches-Castan Emmanuelle Soleilhac Emmanuelle Tillet Olivier Peyruchaud Sabine Bailly

J Exp Clin Cancer Res 2018 Aug 30;37(1):209. Epub 2018 Aug 30.

Univ. Grenoble Alpes, Inserm, CEA, BIG-Biologie du Cancer et de l'Infection, 38000, Grenoble, France.

View Article and Find Full Text PDF
August 2018

The LPA1/ZEB1/miR-21-activation pathway regulates metastasis in basal breast cancer.

Authors:
Debashish Sahay Raphael Leblanc Thomas G P Grunewald Srikant Ambatipudi Johnny Ribeiro Philippe Clézardin Olivier Peyruchaud

Oncotarget 2015 Aug;6(24):20604-20

INSERM, UMR1033, UCB Lyon 1, Faculté de Médecine Lyon Est, Lyon, France.

View Article and Find Full Text PDF
August 2015

Interaction of platelet-derived autotaxin with tumor integrin αVβ3 controls metastasis of breast cancer cells to bone.

Authors:
Raphael Leblanc Sue-Chin Lee Marion David Jean-Claude Bordet Derek D Norman Renukadevi Patil Duane Miller Debashish Sahay Johnny Ribeiro Philippe Clézardin Gabor J Tigyi Olivier Peyruchaud

Blood 2014 Nov 2;124(20):3141-50. Epub 2014 Oct 2.

Institut National de la Santé et de la Recherche Médicale, Unité Mixte de Recherche 1033, Université Claude Bernard Lyon 1, Faculté de Médecine Lyon Est, Lyon, France;

View Article and Find Full Text PDF
November 2014

Identification of heparin-binding EGF-like growth factor (HB-EGF) as a biomarker for lysophosphatidic acid receptor type 1 (LPA1) activation in human breast and prostate cancers.

Authors:
Marion David Debashish Sahay Florence Mege Françoise Descotes Raphaël Leblanc Johnny Ribeiro Philippe Clézardin Olivier Peyruchaud

PLoS One 2014 14;9(5):e97771. Epub 2014 May 14.

INSERM, U1033, Lyon, France; Université Claude Bernard Lyon 1, Villeurbanne, France; Faculté de Médecine Lyon Est, Lyon, France.

View Article and Find Full Text PDF
June 2015

Lysophosphatidic acid receptor type 1 (LPA1) plays a functional role in osteoclast differentiation and bone resorption activity.

Authors:
Marion David Irma Machuca-Gayet Junichi Kikuta Penelope Ottewell Fuka Mima Raphael Leblanc Edith Bonnelye Johnny Ribeiro Ingunn Holen Rùben Lopez Vales Pierre Jurdic Jerold Chun Philippe Clézardin Masaru Ishii Olivier Peyruchaud

J Biol Chem 2014 Mar 15;289(10):6551-64. Epub 2014 Jan 15.

From the INSERM, UMR1033, UCB Lyon 1, Faculté de Médecine Lyon Est, 69732 Lyon, France.

View Article and Find Full Text PDF
March 2014

Targeting lysophosphatidic acid receptor type 1 with Debio 0719 inhibits spontaneous metastasis dissemination of breast cancer cells independently of cell proliferation and angiogenesis.

Authors:
Marion David Johnny Ribeiro Françoise Descotes Claire-Marie Serre Maryse Barbier Maximilien Murone Philippe Clézardin Olivier Peyruchaud

Int J Oncol 2012 Apr 20;40(4):1133-41. Epub 2011 Dec 20.

INSERM, UMR1033, Université de Lyon, Faculté de Médecine Lyon Est, Lyon, France.

View Article and Find Full Text PDF
April 2012

Cancer cell expression of autotaxin controls bone metastasis formation in mouse through lysophosphatidic acid-dependent activation of osteoclasts.

Authors:
Marion David Estelle Wannecq Françoise Descotes Silvia Jansen Blandine Deux Johnny Ribeiro Claire-Marie Serre Sandra Grès Nathalie Bendriss-Vermare Mathieu Bollen Simone Saez Junken Aoki Jean-Sébastien Saulnier-Blache Philippe Clézardin Olivier Peyruchaud

PLoS One 2010 Mar 17;5(3):e9741. Epub 2010 Mar 17.

INSERM, U664, Lyon, France.

View Article and Find Full Text PDF
March 2010